Annual Retained Earnings
-$942.32 M
-$78.02 M-9.03%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual retained earnings is -$942.32 million, with the most recent change of -$78.02 million (-9.03%) on December 31, 2023.
- During the last 3 years, AUPH annual retained earnings has fallen by -$367.17 million (-63.84%).
- AUPH annual retained earnings is now -17130.87% below its all-time high of -$5.47 million, reached on November 30, 1998.
Performance
AUPH Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$938.00 M
+$14.35 M+1.51%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly retained earnings is -$938.00 million, with the most recent change of +$14.35 million (+1.51%) on September 30, 2024.
- Over the past year, AUPH quarterly retained earnings has increased by +$14.35 million (+1.51%).
- AUPH quarterly retained earnings is now -16947.71% below its all-time high of -$5.50 million, reached on February 28, 1999.
Performance
AUPH Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
AUPH Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.0% | +1.5% |
| 3 y3 years | -63.8% | -11.9% |
| 5 y5 years | -126.5% | -11.9% |
AUPH Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -24.6% | at low | -24.1% | +1.6% |
| 5 y | 5-year | -99.4% | at low | -98.5% | +1.6% |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +1.6% |
Aurinia Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$938.00 M(-1.5%) |
| Jun 2024 | - | -$952.35 M(-0.1%) |
| Mar 2024 | - | -$953.07 M(+1.1%) |
| Dec 2023 | -$942.32 M(+9.0%) | -$942.32 M(+2.9%) |
| Sep 2023 | - | -$915.45 M(+1.5%) |
| Jun 2023 | - | -$902.00 M(+1.3%) |
| Mar 2023 | - | -$890.51 M(+3.0%) |
| Dec 2022 | -$864.30 M(+14.3%) | -$864.30 M(+3.1%) |
| Sep 2022 | - | -$838.26 M(+1.1%) |
| Jun 2022 | - | -$829.27 M(+4.5%) |
| Mar 2022 | - | -$793.75 M(+5.0%) |
| Dec 2021 | -$756.12 M(+31.5%) | -$756.12 M(+4.6%) |
| Sep 2021 | - | -$722.80 M(+7.5%) |
| Jun 2021 | - | -$672.54 M(+7.5%) |
| Mar 2021 | - | -$625.53 M(+8.8%) |
| Dec 2020 | -$575.16 M(+21.7%) | -$575.16 M(-7.2%) |
| Sep 2020 | - | -$619.93 M(+11.4%) |
| Mar 2020 | - | -$556.34 M(+17.7%) |
| Dec 2019 | -$472.48 M(+13.6%) | -$472.48 M(+2.0%) |
| Sep 2019 | - | -$463.33 M(+4.3%) |
| Jun 2019 | - | -$444.29 M(+3.7%) |
| Mar 2019 | - | -$428.39 M(+3.0%) |
| Dec 2018 | -$415.96 M(+18.2%) | -$415.96 M(+3.6%) |
| Sep 2018 | - | -$401.37 M(+4.8%) |
| Jun 2018 | - | -$383.02 M(+4.3%) |
| Mar 2018 | - | -$367.32 M(+4.4%) |
| Dec 2017 | -$351.84 M(+25.2%) | -$351.84 M(+1.0%) |
| Sep 2017 | - | -$348.51 M(+3.9%) |
| Jun 2017 | - | -$335.39 M(+0.7%) |
| Mar 2017 | - | -$332.99 M(+18.5%) |
| Dec 2016 | -$281.05 M(+9.0%) | -$281.05 M(+3.1%) |
| Sep 2016 | - | -$272.71 M(+2.8%) |
| Jun 2016 | - | -$265.30 M(+1.3%) |
| Mar 2016 | - | -$262.02 M(+1.7%) |
| Dec 2015 | -$257.75 M(+7.8%) | -$257.75 M(+1.6%) |
| Sep 2015 | - | -$253.69 M(+2.1%) |
| Jun 2015 | - | -$248.48 M(+0.3%) |
| Mar 2015 | - | -$247.75 M(+3.6%) |
| Dec 2014 | -$239.15 M(+8.8%) | -$239.15 M(+3.3%) |
| Sep 2014 | - | -$231.45 M(+1.1%) |
| Jun 2014 | - | -$228.93 M(+1.8%) |
| Mar 2014 | - | -$224.92 M(+2.4%) |
| Dec 2013 | -$219.72 M(+1.2%) | -$219.72 M(+2.9%) |
| Sep 2013 | - | -$213.45 M(+3.1%) |
| Jun 2013 | - | -$206.95 M(-2.9%) |
| Mar 2013 | - | -$213.04 M(-1.9%) |
| Dec 2012 | -$217.06 M(+7.4%) | -$217.06 M(+1.4%) |
| Sep 2012 | - | -$214.15 M(+4.2%) |
| Jun 2012 | - | -$205.56 M(-0.8%) |
| Mar 2012 | - | -$207.20 M(+2.6%) |
| Dec 2011 | -$202.03 M | -$202.03 M(+5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | -$192.49 M(-7.7%) |
| Jun 2011 | - | -$208.55 M(-1.9%) |
| Mar 2011 | - | -$212.68 M(+4.4%) |
| Dec 2010 | -$203.78 M(+6.7%) | -$203.78 M(+4.5%) |
| Sep 2010 | - | -$195.01 M(+3.0%) |
| Jun 2010 | - | -$189.41 M(-3.1%) |
| Mar 2010 | - | -$195.38 M(+2.3%) |
| Dec 2009 | -$190.98 M(+21.0%) | -$190.98 M(+2.9%) |
| Sep 2009 | - | -$185.63 M(+9.6%) |
| Jun 2009 | - | -$169.36 M(+9.0%) |
| Mar 2009 | - | -$155.34 M(-1.5%) |
| Dec 2008 | -$157.78 M(-9.5%) | -$157.78 M(-10.8%) |
| Sep 2008 | - | -$176.81 M(-1.9%) |
| Jun 2008 | - | -$180.25 M(+4.2%) |
| Mar 2008 | - | -$172.96 M(-0.8%) |
| Dec 2007 | -$174.38 M(+46.0%) | -$174.38 M(+5.4%) |
| Sep 2007 | - | -$165.42 M(+12.3%) |
| Jun 2007 | - | -$147.37 M(+15.7%) |
| Mar 2007 | - | -$127.38 M(+6.7%) |
| Dec 2006 | -$119.42 M(+23.2%) | -$119.42 M(+1.3%) |
| Sep 2006 | - | -$117.84 M(+5.4%) |
| Jun 2006 | - | -$111.81 M(+10.5%) |
| Mar 2006 | - | -$101.15 M(+4.4%) |
| Dec 2005 | -$96.91 M(+47.9%) | -$96.91 M(+10.9%) |
| Sep 2005 | - | -$87.42 M(+12.5%) |
| Jun 2005 | - | -$77.71 M(+7.8%) |
| Mar 2005 | - | -$72.10 M(+10.0%) |
| Dec 2004 | -$65.54 M(+64.5%) | -$65.54 M(+19.6%) |
| Sep 2004 | - | -$54.82 M(+21.8%) |
| Jun 2004 | - | -$45.02 M(+6.4%) |
| Mar 2004 | - | -$42.30 M(+6.2%) |
| Dec 2003 | -$39.84 M(+94.1%) | -$39.84 M(+24.5%) |
| Sep 2003 | - | -$32.01 M(+16.6%) |
| Jun 2003 | - | -$27.45 M(+4.7%) |
| Mar 2003 | - | -$26.21 M(+27.7%) |
| Dec 2002 | -$20.52 M(+3.4%) | -$20.52 M(+17.3%) |
| Sep 2002 | - | -$17.50 M(-16.4%) |
| Jun 2002 | - | -$20.92 M(-4.4%) |
| Mar 2002 | - | -$21.88 M(+8.8%) |
| Dec 2001 | -$19.84 M(+53.8%) | - |
| Aug 2001 | - | -$20.11 M(+11.0%) |
| May 2001 | - | -$18.11 M(+20.6%) |
| Feb 2001 | - | -$15.01 M(+16.4%) |
| Nov 2000 | -$12.90 M(+86.2%) | -$12.90 M(+20.1%) |
| Aug 2000 | - | -$10.74 M(+17.4%) |
| May 2000 | - | -$9.14 M(+18.5%) |
| Feb 2000 | - | -$7.72 M(+11.4%) |
| Nov 1999 | -$6.93 M(+26.7%) | -$6.93 M(+17.6%) |
| Aug 1999 | - | -$5.89 M(-2.5%) |
| May 1999 | - | -$6.04 M(+9.7%) |
| Feb 1999 | - | -$5.50 M |
| Nov 1998 | -$5.47 M | - |
FAQ
- What is Aurinia Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual retained earnings year-on-year change?
- What is Aurinia Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly retained earnings year-on-year change?
What is Aurinia Pharmaceuticals annual retained earnings?
The current annual retained earnings of AUPH is -$942.32 M
What is the all time high annual retained earnings for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual retained earnings is -$5.47 M
What is Aurinia Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, AUPH annual retained earnings has changed by -$78.02 M (-9.03%)
What is Aurinia Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of AUPH is -$938.00 M
What is the all time high quarterly retained earnings for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly retained earnings is -$5.50 M
What is Aurinia Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, AUPH quarterly retained earnings has changed by +$14.35 M (+1.51%)